CapitaLand Development has performed well over the review period thanks to achievements in its business parks portfolio in Singapore and China.
The former, unveiled in June 2023, represents CapitaLand’s inaugural unified effort to create a cohesive life sciences and innovation hub. Spanning approximately 180,600 sqm, Geneo was meticulously designed to support biomedical research and development, featuring advanced infrastructure such as high ventilation exhaust systems, versatile laboratory configurations and robust floor load capacities to accommodate specialized equipment.
Access intelligence that drives action
To unlock this research, enter your email to log in or enquire about access
